C. Stoffregen

Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study

Andreas Böhle, H. Leyh, Christian Frei et al. · European Urology · 2009 · 110 citations

Medicine, Oncology, Urology +11

Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma

Jürgen R. Fischer, U. Ohnmacht, Norman Rieger et al. · Lung Cancer · 2006 · 95 citations

Medicine, Cancer Biology, Oncology +16

Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy

Peter A. Kaufman, Masakazu Toi, Patrick Neven et al. · The Oncologist · 2019 · 83 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine

Jürgen R. Fischer, U. Ohnmacht, Norman Rieger et al. · Lung Cancer · 2006 · 75 citations

Medicine, Genetics, Oncology +16

Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin?

P Stieber, A.M. Szymala, Andreas Schalhorn et al. · Oncology Research and Treatment · 2003 · 71 citations · Full text

Medicine, Oncology, Pharmacology +14